Spark Therapeutics buy Quitte
Start price
12.12.17
/
50%
€41.29
Target price
01.02.18
€50.51
Performance (%)
22.74%
End price
01.02.18
€50.68
Summary
This prediction ended on 01.02.18 with a price of €50.68. The BUY prediction by Quitte finished with a performance of 22.74%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Spark Therapeutics | - | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by Quitte for this prediction
In the thread Spark Therapeutics diskutieren
Lux am Ende des Tunnels
Luxturna hat den Priority Review-Status
der 12. Januar dürfte entscheidend sein
ich denke, es gibt Licht am Ende des Tunnels
(Zielkurs erreicht)